CN Stock MarketDetailed Quotes

301087 Cofoe Medical Technology

Watchlist
  • 39.39
  • +1.27+3.33%
Market Closed Dec 12 15:00 CST
8.24BMarket Cap31.16P/E (TTM)

Cofoe Medical Technology Key Stats

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
54.97%1.82B
49.02%1.79B
23.37%1.75B
8.24%1.57B
-8.98%1.18B
-12.61%1.2B
-21.06%1.42B
-27.11%1.45B
948.57%1.29B
573.42%1.37B
Transactional financial assets
-36.89%840.17M
-46.23%709.74M
-31.59%858.84M
-31.54%851.3M
-12.40%1.33B
-12.71%1.32B
-15.42%1.26B
-19.12%1.24B
--1.52B
--1.51B
Notes receivable and accounts receivable
-13.76%395.85M
-3.27%440.87M
2.17%475.51M
-16.17%474.73M
13.18%459M
-6.56%455.76M
1.94%465.42M
63.57%566.27M
23.91%405.54M
102.16%487.75M
-Notes receivable
--178.36K
--119.91K
----
--632.75K
----
----
----
----
--0
----
-Accounts receivable
-13.80%395.67M
-3.29%440.75M
2.17%475.51M
-16.28%474.1M
13.18%459M
-6.56%455.76M
1.94%465.42M
63.57%566.27M
23.91%405.54M
102.16%487.75M
Other receivables (including interest and dividends)
68.66%69.78M
61.01%51.69M
46.80%60.85M
36.38%58M
13.16%41.37M
-37.29%32.11M
24.63%41.45M
68.80%42.53M
-36.44%36.56M
13.46%51.19M
-Other receivable
----
61.01%51.69M
----
----
----
-37.29%32.11M
----
68.80%42.53M
----
13.46%51.19M
Contractual assets
----
----
----
----
----
----
----
----
--0
----
Advance payment
-12.42%131.84M
8.82%133.05M
-23.28%121.11M
-47.54%131.08M
52.65%150.53M
45.58%122.27M
5.91%157.86M
272.90%249.83M
-2.47%98.61M
29.79%83.99M
Inventories
11.63%683.02M
10.12%682.69M
-12.55%607.04M
19.90%634.72M
17.16%611.86M
12.28%619.96M
22.48%694.17M
10.11%529.36M
29.65%522.23M
26.10%552.15M
Receivable financing
-45.72%12.18M
-58.70%14.08M
-41.45%26.28M
-77.88%11.27M
64.54%22.45M
193.40%34.1M
605.60%44.89M
222.09%50.95M
66.10%13.64M
2.00%11.62M
Assets held for sale
----
----
----
----
----
----
----
----
--0
----
Non-current assets due within one year
----
----
----
----
----
----
----
----
--0
----
Other current assets
-39.24%56.53M
26.61%70.26M
13.53%76.79M
46.47%100.22M
26.36%93.04M
-15.66%55.49M
9.23%67.63M
19.33%68.42M
138.50%73.63M
142.47%65.79M
Total current assets
3.24%4.01B
1.31%3.89B
-4.08%3.98B
-8.81%3.83B
-1.93%3.88B
-7.21%3.84B
-9.00%4.14B
-7.04%4.2B
276.90%3.96B
301.11%4.14B
Non Current assets
Investment real estate
--10.49M
--10.67M
----
----
----
----
----
----
--0
----
Long-term equity investment
1,165.27%65.39M
1,148.57%64.82M
1,129.83%64.49M
1,135.26%64.93M
-1.54%5.17M
-2.09%5.19M
-0.97%5.24M
-0.40%5.26M
-2.57%5.25M
10.82%5.3M
Long term receivable account
----
----
----
----
----
----
----
----
--0
----
Fixed assets
----
10.10%1.51B
----
----
----
500.00%1.37B
----
502.65%1.29B
----
20.74%227.94M
Constru in process
----
-34.99%66.66M
----
----
----
-87.74%102.54M
----
-66.29%171.39M
----
312.96%836.18M
Productive biological assets
----
----
----
----
----
----
----
----
--0
----
Oil and gas assets
----
----
----
----
----
----
----
----
--0
----
Intangible assets
-3.82%236.79M
-2.71%237.94M
-3.07%238.82M
-3.10%240.55M
2.38%246.18M
1.24%244.56M
2.54%246.38M
22.73%248.25M
20.37%240.47M
20.11%241.56M
Development expenditure
----
----
----
----
----
----
----
----
--10.5M
--5.72M
Goodwill
51.21%363.72M
57.80%363.72M
42.33%328.06M
5.17%242.41M
5.09%240.55M
0.70%230.5M
253.28%230.5M
374.36%230.5M
1,872.94%228.89M
1,872.94%228.89M
Long deferred expense
-18.08%46.27M
-12.20%49.9M
-3.66%53.21M
-15.57%50.92M
38.54%56.48M
30.05%56.83M
18.40%55.23M
26.31%60.32M
33.36%40.77M
29.49%43.7M
Deferred tax assets
42.33%51.57M
40.44%43.17M
10.79%36.56M
10.53%34.72M
79.34%36.24M
60.75%30.74M
85.12%33M
149.22%31.42M
77.66%20.21M
91.12%19.12M
Usufruct assets
-2.39%132.02M
7.42%131.2M
4.32%139.12M
1.63%138.99M
-20.96%135.25M
-37.82%122.13M
-32.24%133.35M
-12.95%136.76M
83.42%171.11M
109.19%196.4M
Other non current assets
-76.41%12.02M
-51.86%28.56M
-26.10%30.01M
134.00%84.11M
-26.81%50.94M
64.39%59.33M
60.02%40.6M
-60.96%35.95M
8.46%69.6M
32.09%36.09M
Total non current assets
7.49%2.46B
12.75%2.5B
11.94%2.48B
9.20%2.41B
9.35%2.29B
20.56%2.22B
38.64%2.22B
71.56%2.21B
129.72%2.1B
137.92%1.84B
Total assets
4.82%6.47B
5.50%6.39B
1.50%6.46B
-2.60%6.24B
1.98%6.18B
1.35%6.06B
3.38%6.36B
10.40%6.41B
208.51%6.06B
231.15%5.98B
Liabilities
Current liabilities
Short term loan
70.06%557.5M
49.75%459.25M
18.94%339.19M
43.24%402.43M
-11.61%327.83M
-16.70%306.68M
-19.68%285.18M
238.18%280.94M
437.53%370.9M
1,127.23%368.17M
Notes payable and accounts payable
-1.34%452.66M
10.87%522.98M
-5.97%521.73M
-23.93%482.97M
4.04%458.8M
35.46%471.7M
34.59%554.84M
41.68%634.89M
25.73%440.98M
5.47%348.23M
-Notes payable
56.02%113.64M
-10.35%72.79M
2.29%95.12M
-0.80%85.66M
59.17%72.84M
24.12%81.19M
-10.07%93M
-37.58%86.36M
-63.90%45.76M
-43.16%65.41M
-Accounts payable
-12.16%339.02M
15.28%450.19M
-7.63%426.61M
-27.57%397.31M
-2.34%385.96M
38.08%390.51M
49.54%461.84M
77.09%548.53M
76.47%395.22M
31.48%282.81M
Contract liabilities
648.12%3.03M
888.09%3.1M
-26.77%2.79M
9.92%2.8M
-57.11%405.35K
-67.77%314.08K
654.14%3.81M
58.79%2.55M
--945.13K
320.14%974.43K
Advance receipts
59.10%24.86M
141.38%22.29M
53.16%17.7M
118.37%14.04M
129.17%15.63M
33.80%9.23M
48.68%11.56M
-23.44%6.43M
390.19%6.82M
303.32%6.9M
Salaries payable
34.96%37.85M
20.43%36.87M
14.54%37M
1.56%49.57M
-0.80%28.04M
-1.13%30.62M
22.88%32.31M
96.56%48.81M
61.43%28.27M
89.62%30.97M
Taxs payable
-27.82%27.44M
148.48%26.91M
-26.90%28.39M
-78.72%15.83M
47.78%38.01M
-68.34%10.83M
55.55%38.83M
107.30%74.38M
-11.55%25.72M
31.82%34.21M
Other payable (including interest and dividends)
114.56%177.35M
2.32%61.07M
-4.92%61.11M
-25.69%51.07M
49.96%82.66M
-10.02%59.69M
40.80%64.28M
138.56%68.73M
86.23%55.12M
208.39%66.33M
-Dividend payable
--122.04M
----
----
----
----
----
----
----
----
----
-Other payable
----
2.32%61.07M
----
----
----
-10.02%59.69M
----
138.56%68.73M
----
208.89%66.33M
Non current liabilities due within one year
134.42%143.7M
129.11%147.71M
135.06%147.81M
-4.96%67.01M
6.60%61.3M
-14.10%64.47M
4.37%62.88M
35.88%70.5M
180.66%57.5M
97.38%75.05M
Other current liabilities
3,531.73%187.74K
1,119.10%126.23K
----
86.54%684.04K
-91.81%5.17K
-60.93%10.35K
179,107.91%490.69K
6,346.73%366.7K
--63.14K
-12.09%26.5K
Total current liabilities
40.68%1.42B
34.27%1.28B
9.63%1.16B
-8.52%1.09B
2.67%1.01B
2.44%953.55M
13.02%1.05B
73.98%1.19B
90.48%986.32M
100.63%930.86M
Current liabilities
Long term loan
51.98%146.67M
56.69%155.12M
51.04%160.1M
213.37%94.1M
--96.5M
--99M
--106M
--30.03M
----
----
Long term account payable
----
-1.13%6.66M
----
----
----
-42.62%6.73M
----
48.12%7.41M
----
17.32%11.73M
Estimate liabilities
--85K
--85K
--210.56K
--210.56K
----
----
----
----
----
----
Deferred tax liabilities
-35.12%15.54M
-41.89%11.89M
-15.33%15.04M
-5.86%15.7M
159.62%23.95M
155.07%20.46M
195.76%17.77M
282.35%16.68M
167.56%9.23M
126.06%8.02M
Long term deferred income
0.35%55.76M
1.29%56.12M
6.02%56.5M
7.58%55.62M
-1.12%55.57M
-2.29%55.41M
-6.87%53.29M
-9.05%51.7M
0.03%56.2M
0.11%56.71M
Lease liabilities
-1.92%76.26M
4.07%68.28M
-10.50%79.26M
-8.65%77.24M
-22.57%77.75M
-45.06%65.61M
-30.59%88.56M
-9.27%84.55M
32.13%100.41M
100.72%119.42M
Total non current liabilities
15.53%300.98M
20.61%298.15M
16.68%317.77M
31.12%249.6M
46.71%260.51M
26.20%247.21M
39.08%272.35M
19.43%190.36M
21.94%177.57M
51.04%195.88M
Total liabilities
35.53%1.73B
31.46%1.58B
11.08%1.47B
-3.04%1.34B
9.39%1.27B
6.57%1.2B
17.54%1.33B
63.66%1.38B
75.44%1.16B
89.80%1.13B
Shareholders equity
Paid-in capital
0.29%209.09M
0.36%209.24M
0.36%209.24M
0.36%209.24M
0.00%208.49M
0.00%208.49M
30.00%208.49M
30.30%208.49M
73.74%208.49M
73.74%208.49M
Other equity instruments
----
----
----
----
----
----
----
----
--0
----
Capital reserve funds
0.40%3.94B
0.69%3.95B
0.59%3.94B
0.53%3.93B
0.41%3.92B
0.51%3.92B
-0.70%3.91B
-0.12%3.91B
806.91%3.91B
805.32%3.9B
Surplus reserve funds
44.18%111.57M
44.18%111.57M
22.46%94.76M
22.46%94.76M
27.97%77.38M
27.97%77.38M
27.97%77.38M
27.97%77.38M
74.03%60.47M
74.03%60.47M
Retained profit
-16.36%697.27M
-4.84%752.37M
-4.34%929.86M
-1.06%828.64M
15.76%833.69M
15.77%790.65M
13.09%972.02M
3.48%837.5M
1.35%720.22M
9.84%682.97M
Less:Treasury stock
39.78%212.55M
42.66%216.93M
32.38%196.32M
960.64%166.93M
866.12%152.06M
866.12%152.06M
807.69%148.3M
--15.74M
--15.74M
--15.74M
Other composite income
----
----
----
----
----
----
----
----
--0
----
Shareholders equity without minority interests
-3.00%4.74B
-0.85%4.8B
-0.97%4.97B
-2.41%4.9B
0.21%4.89B
0.17%4.84B
0.36%5.02B
1.48%5.02B
276.49%4.88B
300.53%4.84B
Minority interests
-60.20%5.49M
-24.38%10.12M
-23.61%8.73M
-28.39%9M
1.80%13.79M
-11.00%13.39M
-41.42%11.43M
-29.96%12.57M
254.82%13.55M
273.24%15.04M
Total shareholder equity
-3.16%4.75B
-0.91%4.81B
-1.03%4.98B
-2.48%4.91B
0.21%4.9B
0.13%4.86B
0.20%5.03B
1.36%5.03B
276.42%4.89B
300.44%4.85B
Total liabilityies and equity
4.82%6.47B
5.50%6.39B
1.50%6.46B
-2.60%6.24B
1.98%6.18B
1.35%6.06B
3.38%6.36B
10.40%6.41B
208.51%6.06B
231.15%5.98B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds 54.97%1.82B49.02%1.79B23.37%1.75B8.24%1.57B-8.98%1.18B-12.61%1.2B-21.06%1.42B-27.11%1.45B948.57%1.29B573.42%1.37B
Transactional financial assets -36.89%840.17M-46.23%709.74M-31.59%858.84M-31.54%851.3M-12.40%1.33B-12.71%1.32B-15.42%1.26B-19.12%1.24B--1.52B--1.51B
Notes receivable and accounts receivable -13.76%395.85M-3.27%440.87M2.17%475.51M-16.17%474.73M13.18%459M-6.56%455.76M1.94%465.42M63.57%566.27M23.91%405.54M102.16%487.75M
-Notes receivable --178.36K--119.91K------632.75K------------------0----
-Accounts receivable -13.80%395.67M-3.29%440.75M2.17%475.51M-16.28%474.1M13.18%459M-6.56%455.76M1.94%465.42M63.57%566.27M23.91%405.54M102.16%487.75M
Other receivables (including interest and dividends) 68.66%69.78M61.01%51.69M46.80%60.85M36.38%58M13.16%41.37M-37.29%32.11M24.63%41.45M68.80%42.53M-36.44%36.56M13.46%51.19M
-Other receivable ----61.01%51.69M-------------37.29%32.11M----68.80%42.53M----13.46%51.19M
Contractual assets ----------------------------------0----
Advance payment -12.42%131.84M8.82%133.05M-23.28%121.11M-47.54%131.08M52.65%150.53M45.58%122.27M5.91%157.86M272.90%249.83M-2.47%98.61M29.79%83.99M
Inventories 11.63%683.02M10.12%682.69M-12.55%607.04M19.90%634.72M17.16%611.86M12.28%619.96M22.48%694.17M10.11%529.36M29.65%522.23M26.10%552.15M
Receivable financing -45.72%12.18M-58.70%14.08M-41.45%26.28M-77.88%11.27M64.54%22.45M193.40%34.1M605.60%44.89M222.09%50.95M66.10%13.64M2.00%11.62M
Assets held for sale ----------------------------------0----
Non-current assets due within one year ----------------------------------0----
Other current assets -39.24%56.53M26.61%70.26M13.53%76.79M46.47%100.22M26.36%93.04M-15.66%55.49M9.23%67.63M19.33%68.42M138.50%73.63M142.47%65.79M
Total current assets 3.24%4.01B1.31%3.89B-4.08%3.98B-8.81%3.83B-1.93%3.88B-7.21%3.84B-9.00%4.14B-7.04%4.2B276.90%3.96B301.11%4.14B
Non Current assets
Investment real estate --10.49M--10.67M--------------------------0----
Long-term equity investment 1,165.27%65.39M1,148.57%64.82M1,129.83%64.49M1,135.26%64.93M-1.54%5.17M-2.09%5.19M-0.97%5.24M-0.40%5.26M-2.57%5.25M10.82%5.3M
Long term receivable account ----------------------------------0----
Fixed assets ----10.10%1.51B------------500.00%1.37B----502.65%1.29B----20.74%227.94M
Constru in process -----34.99%66.66M-------------87.74%102.54M-----66.29%171.39M----312.96%836.18M
Productive biological assets ----------------------------------0----
Oil and gas assets ----------------------------------0----
Intangible assets -3.82%236.79M-2.71%237.94M-3.07%238.82M-3.10%240.55M2.38%246.18M1.24%244.56M2.54%246.38M22.73%248.25M20.37%240.47M20.11%241.56M
Development expenditure ----------------------------------10.5M--5.72M
Goodwill 51.21%363.72M57.80%363.72M42.33%328.06M5.17%242.41M5.09%240.55M0.70%230.5M253.28%230.5M374.36%230.5M1,872.94%228.89M1,872.94%228.89M
Long deferred expense -18.08%46.27M-12.20%49.9M-3.66%53.21M-15.57%50.92M38.54%56.48M30.05%56.83M18.40%55.23M26.31%60.32M33.36%40.77M29.49%43.7M
Deferred tax assets 42.33%51.57M40.44%43.17M10.79%36.56M10.53%34.72M79.34%36.24M60.75%30.74M85.12%33M149.22%31.42M77.66%20.21M91.12%19.12M
Usufruct assets -2.39%132.02M7.42%131.2M4.32%139.12M1.63%138.99M-20.96%135.25M-37.82%122.13M-32.24%133.35M-12.95%136.76M83.42%171.11M109.19%196.4M
Other non current assets -76.41%12.02M-51.86%28.56M-26.10%30.01M134.00%84.11M-26.81%50.94M64.39%59.33M60.02%40.6M-60.96%35.95M8.46%69.6M32.09%36.09M
Total non current assets 7.49%2.46B12.75%2.5B11.94%2.48B9.20%2.41B9.35%2.29B20.56%2.22B38.64%2.22B71.56%2.21B129.72%2.1B137.92%1.84B
Total assets 4.82%6.47B5.50%6.39B1.50%6.46B-2.60%6.24B1.98%6.18B1.35%6.06B3.38%6.36B10.40%6.41B208.51%6.06B231.15%5.98B
Liabilities
Current liabilities
Short term loan 70.06%557.5M49.75%459.25M18.94%339.19M43.24%402.43M-11.61%327.83M-16.70%306.68M-19.68%285.18M238.18%280.94M437.53%370.9M1,127.23%368.17M
Notes payable and accounts payable -1.34%452.66M10.87%522.98M-5.97%521.73M-23.93%482.97M4.04%458.8M35.46%471.7M34.59%554.84M41.68%634.89M25.73%440.98M5.47%348.23M
-Notes payable 56.02%113.64M-10.35%72.79M2.29%95.12M-0.80%85.66M59.17%72.84M24.12%81.19M-10.07%93M-37.58%86.36M-63.90%45.76M-43.16%65.41M
-Accounts payable -12.16%339.02M15.28%450.19M-7.63%426.61M-27.57%397.31M-2.34%385.96M38.08%390.51M49.54%461.84M77.09%548.53M76.47%395.22M31.48%282.81M
Contract liabilities 648.12%3.03M888.09%3.1M-26.77%2.79M9.92%2.8M-57.11%405.35K-67.77%314.08K654.14%3.81M58.79%2.55M--945.13K320.14%974.43K
Advance receipts 59.10%24.86M141.38%22.29M53.16%17.7M118.37%14.04M129.17%15.63M33.80%9.23M48.68%11.56M-23.44%6.43M390.19%6.82M303.32%6.9M
Salaries payable 34.96%37.85M20.43%36.87M14.54%37M1.56%49.57M-0.80%28.04M-1.13%30.62M22.88%32.31M96.56%48.81M61.43%28.27M89.62%30.97M
Taxs payable -27.82%27.44M148.48%26.91M-26.90%28.39M-78.72%15.83M47.78%38.01M-68.34%10.83M55.55%38.83M107.30%74.38M-11.55%25.72M31.82%34.21M
Other payable (including interest and dividends) 114.56%177.35M2.32%61.07M-4.92%61.11M-25.69%51.07M49.96%82.66M-10.02%59.69M40.80%64.28M138.56%68.73M86.23%55.12M208.39%66.33M
-Dividend payable --122.04M------------------------------------
-Other payable ----2.32%61.07M-------------10.02%59.69M----138.56%68.73M----208.89%66.33M
Non current liabilities due within one year 134.42%143.7M129.11%147.71M135.06%147.81M-4.96%67.01M6.60%61.3M-14.10%64.47M4.37%62.88M35.88%70.5M180.66%57.5M97.38%75.05M
Other current liabilities 3,531.73%187.74K1,119.10%126.23K----86.54%684.04K-91.81%5.17K-60.93%10.35K179,107.91%490.69K6,346.73%366.7K--63.14K-12.09%26.5K
Total current liabilities 40.68%1.42B34.27%1.28B9.63%1.16B-8.52%1.09B2.67%1.01B2.44%953.55M13.02%1.05B73.98%1.19B90.48%986.32M100.63%930.86M
Current liabilities
Long term loan 51.98%146.67M56.69%155.12M51.04%160.1M213.37%94.1M--96.5M--99M--106M--30.03M--------
Long term account payable -----1.13%6.66M-------------42.62%6.73M----48.12%7.41M----17.32%11.73M
Estimate liabilities --85K--85K--210.56K--210.56K------------------------
Deferred tax liabilities -35.12%15.54M-41.89%11.89M-15.33%15.04M-5.86%15.7M159.62%23.95M155.07%20.46M195.76%17.77M282.35%16.68M167.56%9.23M126.06%8.02M
Long term deferred income 0.35%55.76M1.29%56.12M6.02%56.5M7.58%55.62M-1.12%55.57M-2.29%55.41M-6.87%53.29M-9.05%51.7M0.03%56.2M0.11%56.71M
Lease liabilities -1.92%76.26M4.07%68.28M-10.50%79.26M-8.65%77.24M-22.57%77.75M-45.06%65.61M-30.59%88.56M-9.27%84.55M32.13%100.41M100.72%119.42M
Total non current liabilities 15.53%300.98M20.61%298.15M16.68%317.77M31.12%249.6M46.71%260.51M26.20%247.21M39.08%272.35M19.43%190.36M21.94%177.57M51.04%195.88M
Total liabilities 35.53%1.73B31.46%1.58B11.08%1.47B-3.04%1.34B9.39%1.27B6.57%1.2B17.54%1.33B63.66%1.38B75.44%1.16B89.80%1.13B
Shareholders equity
Paid-in capital 0.29%209.09M0.36%209.24M0.36%209.24M0.36%209.24M0.00%208.49M0.00%208.49M30.00%208.49M30.30%208.49M73.74%208.49M73.74%208.49M
Other equity instruments ----------------------------------0----
Capital reserve funds 0.40%3.94B0.69%3.95B0.59%3.94B0.53%3.93B0.41%3.92B0.51%3.92B-0.70%3.91B-0.12%3.91B806.91%3.91B805.32%3.9B
Surplus reserve funds 44.18%111.57M44.18%111.57M22.46%94.76M22.46%94.76M27.97%77.38M27.97%77.38M27.97%77.38M27.97%77.38M74.03%60.47M74.03%60.47M
Retained profit -16.36%697.27M-4.84%752.37M-4.34%929.86M-1.06%828.64M15.76%833.69M15.77%790.65M13.09%972.02M3.48%837.5M1.35%720.22M9.84%682.97M
Less:Treasury stock 39.78%212.55M42.66%216.93M32.38%196.32M960.64%166.93M866.12%152.06M866.12%152.06M807.69%148.3M--15.74M--15.74M--15.74M
Other composite income ----------------------------------0----
Shareholders equity without minority interests -3.00%4.74B-0.85%4.8B-0.97%4.97B-2.41%4.9B0.21%4.89B0.17%4.84B0.36%5.02B1.48%5.02B276.49%4.88B300.53%4.84B
Minority interests -60.20%5.49M-24.38%10.12M-23.61%8.73M-28.39%9M1.80%13.79M-11.00%13.39M-41.42%11.43M-29.96%12.57M254.82%13.55M273.24%15.04M
Total shareholder equity -3.16%4.75B-0.91%4.81B-1.03%4.98B-2.48%4.91B0.21%4.9B0.13%4.86B0.20%5.03B1.36%5.03B276.42%4.89B300.44%4.85B
Total liabilityies and equity 4.82%6.47B5.50%6.39B1.50%6.46B-2.60%6.24B1.98%6.18B1.35%6.06B3.38%6.36B10.40%6.41B208.51%6.06B231.15%5.98B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.